HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$1.62
Day range
$1.49 - $1.73
Year range
$1.30 - $11.51
Market cap
47.03M USD
Avg Volume
197.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.95M | 18.53% |
Net income | -22.83M | -18.59% |
Net profit margin | — | — |
Earnings per share | -0.54 | 37.93% |
EBITDA | -24.65M | -17.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 179.48M | 40.82% |
Total assets | 196.59M | 42.18% |
Total liabilities | 19.80M | 16.00% |
Total equity | 176.79M | — |
Shares outstanding | 31.35M | — |
Price to book | 0.29 | — |
Return on assets | -30.34% | — |
Return on capital | -32.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.83M | -18.59% |
Cash from operations | -17.36M | -40.38% |
Cash from investing | 14.41M | -29.82% |
Cash from financing | -647.00K | 67.83% |
Net change in cash | -3.60M | -158.37% |
Free cash flow | -10.65M | -51.52% |
About
Founded
2018
Headquarters
Website
Employees
77
